Drugs / Phenindione
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT03153150 | Mar 2018 → Mar 2021 | atrial fibrillation, atrial flutter, intracerebral hemorrhage, subarachnoid hemorrhage | University of Edinburgh | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01758640 Comparator | Feb 2010 → Jun 2012 | — | Yasser Elnahas | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phenindione | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03153150 ↗ |
| Known as | Danilone | ChEMBL registry synonym — accepted as the source's own label CHEMBL711 ↗ |
| Known as | Dindevan | ChEMBL registry synonym — accepted as the source's own label CHEMBL711 ↗ |
| Known as | Fenindiona | ChEMBL registry synonym — accepted as the source's own label CHEMBL711 ↗ |
| Known as | Hedulin | ChEMBL registry synonym — accepted as the source's own label CHEMBL711 ↗ |
| Known as | NSC-41693 | ChEMBL registry synonym — accepted as the source's own label CHEMBL711 ↗ |
| Action | Inhibit | “Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor” CHEMBL711 ↗ |
| Modality | Small molecule | — CHEMBL711 ↗ |
| Target | VKORC1 | “Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor” CHEMBL711 ↗ |